Patents Assigned to Theriod Biologics, Incorporated
  • Patent number: 5614404
    Abstract: Recombinant viral vectors which coexpress heterologous polypeptides capable of assembling into defective nonself-propagating viral particles are disclosed. The viral vectors as well as the viral particles can be used as immunogens and for targeted delivery of heterologous gene products and drugs.
    Type: Grant
    Filed: December 21, 1992
    Date of Patent: March 25, 1997
    Assignee: Theriod Biologics, Incorporated
    Inventors: Gail P. Mazzara, Bryan Roberts, Dennis L. Panicali, Virginia Stallard, Linda R. Gritz, Anna Mahe